Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

3.

Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.

Singh S, Reddy DC, Pandey SS.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 1):61-5.

PMID:
10863225
4.

Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.

Ortonne JP, Esposito M, Chimenti S, Kapińska-Mrowiecka M, Grodzińska A, Naldi L, Frangione V.

J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1226-34. doi: 10.1111/jdv.12270. Epub 2013 Oct 29.

5.

A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

Jemec GB, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, Berne B, Figueiredo A, Austad J.

J Am Acad Dermatol. 2008 Sep;59(3):455-63. doi: 10.1016/j.jaad.2008.04.027.

PMID:
18694678
6.

Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.

Koo J, Tyring S, Werschler WP, Bruce S, Olesen M, Villumsen J, Bagel J.

J Dermatolog Treat. 2016;27(2):120-7. doi: 10.3109/09546634.2015.1083935. Epub 2015 Oct 7.

7.
9.

Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.

White S, Vender R, Thaçi D, Haverkamp C, Naeyaert JM, Foster R, Martinez Escribano JA, Cambazard F, Bibby A.

Am J Clin Dermatol. 2006;7(3):177-84.

PMID:
16734505
10.

Fixed-dose combination therapy for psoriasis.

Guenther LC.

Am J Clin Dermatol. 2004;5(2):71-7. Review. Erratum in: Am J Clin Dermatol. 2004;5(4):279.

PMID:
15109271
11.

Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.

McCormack PL.

Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Review.

PMID:
21967117
12.

Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.

Menter A, Gold LS, Bukhalo M, Grekin S, Kempers S, Boyce BM, Ganslandt C, Villumsen J, Lebwohl M.

J Drugs Dermatol. 2013 Jan;12(1):92-8.

PMID:
23377334
14.

Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.

Camarasa JM, Ortonne JP, Dubertret L.

J Dermatolog Treat. 2003 Jan;14(1):8-13.

PMID:
12745849
15.

Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.

Alora-Palli MB, Perkins AC, Van Cott A, Kimball AB.

Am J Clin Dermatol. 2010;11(4):275-83. doi: 10.2165/11530380-000000000-00000.

PMID:
20513160
17.

Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment.

Abramovits W, Perlmutter A, Gupta AK.

Skinmed. 2006 May-Jun;5(3):136-8. No abstract available.

PMID:
16687982
18.

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.

Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, Krogstad AL, Larsen FG, Iglesias L, Buckley C, Bibby AJ.

Acta Derm Venereol. 2002;82(2):131-5.

PMID:
12125943
19.

Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis.

Bruce S, Epinette WW, Funicella T, Ison A, Jones EL, Loss R Jr, McPhee ME, Whitmore C.

J Am Acad Dermatol. 1994 Nov;31(5 Pt 1):755-9.

PMID:
7929921

Supplemental Content

Support Center